| Issue Date | Title | Author(s) |
| 2017-10-01 | Synthesis and in vitro biological evaluation of thiosulfinate derivatives for the treatment of human multidrug-resistant breast cancer | Roseblade, A; Ung, A; Bebawy, M |
| 2012-01-01 | Microparticle-associated nucleic acids mediate trait dominance in cancer | Jaiswal, R; Gong, J; Sambasivam, S; Combes, V; Mathys, JM; Davey, R; Grau, GER; Bebawy, M |
| 2004-01-01 | Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease | Martiniello-Wilks, R; Dane, A; Voeks, DJ; Jeyakumar, G; Mortensen, E; Shaw, JM; Wang, XY; Both, GW; Russell, PJ |
| 2016-01-01 | Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma | Tayao, M; Andrici, J; Farzin, M; Clarkson, A; Sioson, L; Watson, N; Chua, TC; Sztynda, T; Samra, JS; Gill, AJ |
| 1994-11 | Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. | Jenkins, DC; Charles, IG; Baylis, SA; Lelchuk, R; Radomski, MW; Moncada, S |
| 1998-07-20 | In vivo gene therapy for prostate cancer: Preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors | Martiniello-Wilks, R; Garcia-Aragon, J; Daja, MM; Russell, P; Both, GW; Molloy, PL; Lockett, LJ; Russell, PJ |
| 2012-02-01 | A single nucleotide polymorphism in EXO1 gene is associated with cervical cancer susceptibility in chinese patients | Luo, X; Hong, XS; Xiong, XD; Zeng, LQ; Lim, CED |
| 1995-05-09 | Roles of nitric oxide in tumor growth. | Jenkins, DC; Charles, IG; Thomsen, LL; Moss, DW; Holmes, LS; Baylis, SA; Rhodes, P; Westmore, K; Emson, PC; Moncada, S |
| 2020-02 | MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. | Castillo, L; Young, AIJ; Mawson, A; Schafranek, P; Steinmann, AM; Nessem, D; Parkin, A; Johns, A; Chou, A; Law, AMK; Lucas, MC; Murphy, KJ; Deng, N; Gallego-Ortega, D; Caldon, CE; Australian Pancreatic Cancer Genome Initiative (APGI); Timpson, P; Pajic, M; Ormandy, CJ; Oakes, SR |
| 2023-03-22 | A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death. | Fares, M; Wu, X; McNaughton, DA; Gilchrist, AM; Lewis, W; Keller, PA; Arias-Betancur, A; Fontova, P; Pérez-Tomás, R; Gale, PA |
